NTAGI recommends reducing Covid booster dose gap to 6 months


NTAGI’s Standing Technical Subcommittee (STSC) on Thursday recommended narrowing the gap between second doses and precautionary doses of COVID-19 vaccines for the current nine to six months, official sources said. They said the Department of Health will soon take the final call on the recommendation.

The government advisory group, which met on Thursday, also considered the findings of a study by Vellore’s Christian Medical College (CMC) on the feasibility of authorizing a different Covid vaccine as a precautionary dose to that used for primo -vaccination. Panel members noted a lack of uniformity in results when mixing jabs for booster shots and said no recommendations on this could be made at this time. The CMC study focused on Covishield and Covaxin.

The threat of monkeypox and the requirement for vaccination was also discussed at the National Technical Advisory Group on Immunization (NTAGI) meeting, the sources said.

”However, members were of the view that strong oversight is what is needed now. No cases of monkeypox have been detected in the country so far,” one of the sources told PTI.

The panel also looked at data on the Covaxin and Corbevax vaccines for the 6-12 year age group.

“Members felt that the data on the burden and mortality of Covid in children is not strong enough to make a decision to start vaccination of under-12s,” the source said.

In April this year, India’s drug regulator granted emergency use authorization for Biological E’s COVID-19 vaccine Corbevax for people aged five to 12 and Bharat Biotech’s Covaxin for children aged six. at the age of 12.

Members of the STSC learned that they have also agreed on the administration of an additional third dose for kidney transplant patients before the precautionary dose.

“At today’s meeting, members also agreed to reduce the gap between the second and precautionary doses of COVID-19 vaccines from the current nine months to six months based on scientific evidence and data. “, the source told PTI.

Currently, everyone over the age of 18 who has completed nine months after receiving the second dose is eligible for the precautionary dose.

Last month, the Union government allowed citizens and students traveling abroad to be vaccinated before the stipulated nine-month waiting period, as required by destination country guidelines.

(This story has not been edited by the Devdiscourse team and is auto-generated from a syndicated feed.)


Comments are closed.